View a ticker or compare two or three
SAGE
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SAGE is expected to report earnings to fall 9.44% to -162 cents per share on July 31

Sage Therapeutics SAGE Stock Earnings Reports
Q2'24
Est.
$-1.63
Q1'24
Missed
by $0.15
Q4'23
Beat
by $0.73
Q3'23
Missed
by $0.69
Q2'23
Missed
by $0.13
The last earnings report on April 25 showed earnings per share of -179 cents, missing the estimate of -164 cents. With 815.02K shares outstanding, the current market capitalization sits at 739.64M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REAIX25.67-0.03
-0.12%
American Century Real Estate I
BMISX7.75-0.05
-0.64%
BNY Mellon Income Stock C
FSCTX27.34-0.19
-0.69%
Fidelity Advisor Small Cap M
FVLCX21.89-0.17
-0.77%
Fidelity Advisor Value Leaders C
FEQMX39.34-0.39
-0.98%
Fidelity Advisor Emerging Markets M

SAGE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SAGE has been loosely correlated with QSI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SAGE jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAGE
1D Price
Change %
SAGE100%
+0.99%
QSI - SAGE
42%
Loosely correlated
-5.50%
AXON - SAGE
42%
Loosely correlated
+0.91%
JAZZ - SAGE
40%
Loosely correlated
+0.16%
SRPT - SAGE
39%
Loosely correlated
+1.27%
CNTA - SAGE
37%
Loosely correlated
-1.05%
More